TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12160204

Group type: EXPERIMENTAL
Intervention: Oral tobramycin and metronidazole for three days prior to surgery
Number of subjects: 137

Group type: COMPARATOR
Intervention: Systemic antibiotic cefmetazole every 3 hours during surgery
Number of subjects: 137

Group type: COMPARATOR
Intervention: Systemic antibiotic cefmetazole every 3 hours during surgery and luminal preparation of tobramycin during surgery
Number of subjects: 137
Study: 8276939

Group type: EXPERIMENTAL
Intervention: Scopolamine
Number of subjects: 0
Study: 3793028

Group type: EXPERIMENTAL
Intervention: Axillary extracts from female donors
Number of subjects: 0

Group type: COMPARATOR
Intervention: Blank/ethanol
Number of subjects: 0
Study: 31574170

Group type: EXPERIMENTAL
Intervention: 1 L polyethylene glycol plus ascorbic acid with bisacodyl suppository
Number of subjects: 168

Group type: COMPARATOR
Intervention: 2 L polyethylene glycol plus ascorbic acid
Number of subjects: 168
Study: 31421096

Group type: EXPERIMENTAL
Intervention: Bilateral Hybrid Therapy (BHT)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Robot-assisted Therapy (RT)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Unilateral Hybrid Therapy (UHT)
Number of subjects: 44
Study: 29135426

Group type: EXPERIMENTAL
Intervention: Integrated Supported Employment (ISE)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Individual Placement and Support (IPS)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Traditional Vocational Rehabilitation (TVR)
Number of subjects: 162
Study: 26133561

Group type: EXPERIMENTAL
Intervention: TAC spray with no rubbing
Number of subjects: 50

Group type: COMPARATOR
Intervention: TAC spray with rubbing
Number of subjects: 50
Study: 23804385

Group type: EXPERIMENTAL
Intervention: Hybrid Capture 2 (HC2) test
Number of subjects: 2920
Study: 21633800

Group type: EXPERIMENTAL
Intervention: Advance motor information conditions
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Age of disease onset
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Cerebellar impairment
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control participants
Number of subjects: 13
Study: 20166436

Group type: EXPERIMENTAL
Intervention: Promethazine hydrochloride determination method using LC-MS in human plasma (0.5 ml)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Promethazine hydrochloride determination method using LC-MS in human urine (0.1 ml)
Number of subjects: 0
Study: 16723363

Group type: EXPERIMENTAL
Intervention: Syndromic STI packages (containing antibiotics, condoms, partner notification cards, and written information)
Number of subjects: 525
Study: 15312096

Group type: EXPERIMENTAL
Intervention: AmF/SnF2-containing mouthrinse
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control mouthrinse
Number of subjects: 18
Study: 11416871

Group type: EXPERIMENTAL
Intervention: Inhaled Nitric Oxide (INO) weaning from 40 ppm
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Discontinuation of INO
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: INO weaning with surfactant therapy
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: INO weaning with specific dose reduction
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Prewean PaO(2)
Number of subjects: 84
Study: 9576635

Group type: EXPERIMENTAL
Intervention: CD18 immunofluorescence measurement in patients with acute ischemic stroke
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (20 patients with other neurological diseases)
Number of subjects: 20
Study: 7889886

Group type: EXPERIMENTAL
Intervention: Boron supplementation
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 3259128

Group type: COMPARATOR
Intervention: Saphenous vein graft (Group 1)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Left internal mammary artery graft (Group 2)
Number of subjects: 80
Study: 31928077

Group type: EXPERIMENTAL
Intervention: Higher iron status (as determined by SNPs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lower iron status (as determined by SNPs)
Number of subjects: 0
Study: 29957756

Group type: EXPERIMENTAL
Intervention: Continue metformin during peri-angiography (M (+) group)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Stop metformin 24 hours prior to procedure (M (−) group)
Number of subjects: 162
Study: 26202461

Group type: EXPERIMENTAL
Intervention: Trauma-focused cognitive behavioural therapy (TF-CBT)
Number of subjects: 26
Study: 26485477

Group type: EXPERIMENTAL
Intervention: Glenohumeral posterior mobilization technique after training with a cycle ergometer
Number of subjects: 57

Group type: COMPARATOR
Intervention: Conventional physiotherapy
Number of subjects: 57
Study: 23312430

Group type: EXPERIMENTAL
Intervention: Cognitive refocusing treatment for insomnia (CRT-I) + sleep hygiene education (SH)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Sleep hygiene education (SH)
Number of subjects: 51
Study: 21677695

Group type: EXPERIMENTAL
Intervention: Candesartan (ARB)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Amlodipine (CCB)
Number of subjects: 113
Study: 19086244

Group type: COMPARATOR
Intervention: Metronidazole (400 mg t.i.d.)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Clostridium difficile immune whey (CDIW) (200 ml t.i.d.)
Number of subjects: 38
Study: 16863724

Group type: EXPERIMENTAL
Intervention: Clover honey (50 g carbohydrate)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Buckwheat honey (50 g carbohydrate)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cotton honey (50 g carbohydrate)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Tupelo honey (50 g carbohydrate)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Glucose solution (50 g carbohydrate)
Number of subjects: 12
Study: 12880704

Group type: EXPERIMENTAL
Intervention: Subjects with diabetes and a history of recurrent plantar ulcers
Number of subjects: 30
Study: 10858637

Group type: EXPERIMENTAL
Intervention: Postnatal support from a community midwifery support worker (SW) offering ten visits in the first 28 days postnatally, for up to 3 hours per day.
Number of subjects: 623

Group type: COMPARATOR
Intervention: Control group (no postnatal support).
Number of subjects: 623
Study: 8653433

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 248

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 248
Study: 2302973

Group type: COMPARATOR
Intervention: Solid boluses (yogurt and gelatin)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Water bolus
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Boluses with varying temperatures (1°C to 60°C)
Number of subjects: 20
Study: 6103450

Group type: EXPERIMENTAL
Intervention: Blood-glucose self-monitoring (meter)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Conventionally treated (non-meter)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Normal pregnant women (control)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Home control
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Hospital admission
Number of subjects: 13
Study: 31714309

Group type: EXPERIMENTAL
Intervention: Single preoperative intravenous co‐amoxiclav
Number of subjects: 293

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 293
Study: 30399442

Group type: EXPERIMENTAL
Intervention: Patient Navigation Services (PNs) intervention
Number of subjects: 300
Study: 28407505

Group type: EXPERIMENTAL
Intervention: AFO-provision early (at inclusion)
Number of subjects: 20
Study: 25452632

Group type: EXPERIMENTAL
Intervention: Physical rehabilitation
Number of subjects: 538

Group type: EXPERIMENTAL
Intervention: Geriatric rehabilitation
Number of subjects: 538

Group type: COMPARATOR
Intervention: Control group (health centre hospital rehabilitation)
Number of subjects: 538
Study: 24369397

Group type: EXPERIMENTAL
Intervention: Functional jejunal interposition (FJI)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Roux-en-Y (R-Y)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 109
Study: 21738025

Group type: EXPERIMENTAL
Intervention: Zonisamide (50 mg/d, titrated up to 200 mg/d)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Topiramate (25 mg/d, titrated up to 100 mg/d)
Number of subjects: 80
Study: 19824837

Group type: EXPERIMENTAL
Intervention: Respeto/Proteger: Respecting and Protecting Our Relationships program; details on dosage and duration not available.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Parental protectiveness; details on dosage and duration not available.
Number of subjects: 0
Study: 16395251

Group type: EXPERIMENTAL
Intervention: Intravenous vitamin C (VC) infusion, n=20
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Vitamin E (VE)-coated dialyzer, n=20
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Intravenous vitamin C plus VE-coated dialyzer, n=20
Number of subjects: 80

Group type: COMPARATOR
Intervention: Neither intervention (control group), n=20
Number of subjects: 80
Study: 15248137

Group type: EXPERIMENTAL
Intervention: ZDV/3TC/NVP
Number of subjects: 127

Group type: COMPARATOR
Intervention: ZDV/3TC/NFV
Number of subjects: 127
Study: 11032269

Group type: EXPERIMENTAL
Intervention: Epidural anesthesia
Number of subjects: 27

Group type: COMPARATOR
Intervention: Spinal anesthesia
Number of subjects: 27
Study: 9023238

Group type: EXPERIMENTAL
Intervention: Ketorolac tromethamine (KT)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Meperidine (MP)
Number of subjects: 80
Study: 7974894

Group type: EXPERIMENTAL
Intervention: Biologic therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cytokine therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cytoreductive nephrectomy
Number of subjects: 0
Study: 3589707

Group type: EXPERIMENTAL
Intervention: Megestrol acetate
Number of subjects: 197

Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 197
Study: 30538796

Group type: EXPERIMENTAL
Intervention: Ropivacaine (200 mg intraoperative, 100 mg postoperative every 8 hours for 2 days)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 49
Study: 27879595

Group type: EXPERIMENTAL
Intervention: Pamphlet of surgical risks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no pamphlet)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Pamphlet group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Reading about surgery
Number of subjects: 60
Study: 24710974

Group type: COMPARATOR
Intervention: OT
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: OT plus EMG‐biofeedback therapy
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: OT plus neurofeedback therapy
Number of subjects: 30
Study: 22392815

Group type: EXPERIMENTAL
Intervention: Union commitment
Number of subjects: 1817

Group type: EXPERIMENTAL
Intervention: Exposure to dust
Number of subjects: 1817

Group type: EXPERIMENTAL
Intervention: Exposure to chemicals
Number of subjects: 1817

Group type: EXPERIMENTAL
Intervention: Concern about exposure to occupational hazards
Number of subjects: 1817
Study: 20032498

Group type: EXPERIMENTAL
Intervention: Molecular remission (MR) after rituximab-based induction treatment
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: Molecular remission (MR) in bone marrow (BM) MRD-negative complete response (CR) and partial response (PR)
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: Sustained molecular remission (MR) during postinduction period
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: Sustained molecular remission (MR) during maintenance in MCL Elderly
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: Autologous stem cell transplantation (ASCT)
Number of subjects: 259
Study: 18096137

Group type: EXPERIMENTAL
Intervention: Bupropion SR (300 mg/day) + Transdermal Nicotine Patch (21 mg/24h)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo + Transdermal Nicotine Patch (21 mg/24h)
Number of subjects: 58
Study: 16155368

Group type: EXPERIMENTAL
Intervention: Etanercept (25 mg subcutaneously twice weekly for 4 weeks)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 20
Study: 12799329

Group type: EXPERIMENTAL
Intervention: Intra‐abdominal operations
Number of subjects: 1021
Study: 9920522

Group type: EXPERIMENTAL
Intervention: Plasma PLTP activity
Number of subjects: 52
Study: 8865828

Group type: EXPERIMENTAL
Intervention: Oxygen supplementation via nasal prongs
Number of subjects: 289

Group type: COMPARATOR
Intervention: No oxygen supplementation
Number of subjects: 289
Study: 1555329

Group type: EXPERIMENTAL
Intervention: Salbutamol (0.400 mg)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Helium (He) + Oxygen (O2) breathing
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Salbutamol after equilibration with He + O2
Number of subjects: 21
Study: 3157318

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dazoxiben
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30241564

Group type: EXPERIMENTAL
Intervention: Persuasive message (reciprocity)
Number of subjects: 1085322

Group type: COMPARATOR
Intervention: Control prompt
Number of subjects: 1085322

Group type: EXPERIMENTAL
Intervention: Loss-framed message
Number of subjects: 1085322

Group type: EXPERIMENTAL
Intervention: Social norms message plus image
Number of subjects: 1085322
Study: 26523836

Group type: EXPERIMENTAL
Intervention: Hydroxycarbamide (hydroxyurea)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Chronic transfusion therapy
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 121
Study: 25154195

Group type: EXPERIMENTAL
Intervention: High-tone power therapy for 60 minutes for 15 days
Number of subjects: 20

Group type: COMPARATOR
Intervention: Kinesis exercises for 15 days
Number of subjects: 20
Study: 22236402

Group type: EXPERIMENTAL
Intervention: Test meals varying in type and amount of fat
Number of subjects: 20
Study: 20820117

Group type: EXPERIMENTAL
Intervention: Sanhujori facilities
Number of subjects: 55

Group type: COMPARATOR
Intervention: Not using Sanhujori facilities
Number of subjects: 55
Study: 18258342

Group type: EXPERIMENTAL
Intervention: Intravenous alanyl-Gln dipeptide (AG) supplementation (0.5 g/kg/day)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Enteral alanyl-Gln dipeptide (AG) supplementation (0.32±0.02 g/kg/day)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (Gln-free tube feedings)
Number of subjects: 44
Study: 15723741

Group type: EXPERIMENTAL
Intervention: Early enteral nutrition (EEN) group, receiving 3 to 5 mL of breast milk every hour through a nasogastric feeding tube, starting a mean of 12 h after surgery
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Early enteral nutrition (EEN) group
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 56
Study: 14607208

Group type: EXPERIMENTAL
Intervention: Metoprolol, 50 mg t.i.d. for 6 months
Number of subjects: 0
Study: 10808175

Group type: EXPERIMENTAL
Intervention: Oral prednisolone (40 mg/day) for 9 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo therapy
Number of subjects: 0
Study: 9014715

Group type: EXPERIMENTAL
Intervention: Dalteparin and Ringer's acetate
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Dalteparin and dextran
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Dextran and Ringer's acetate
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Dextran and dextran
Number of subjects: 198
Study: 1325348

Group type: EXPERIMENTAL
Intervention: Phosphatidylserine 800 mg/d for 10 days
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 6617682

Group type: EXPERIMENTAL
Intervention: Pindolol 15 mg daily
Number of subjects: 529

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 529

Group type: EXPERIMENTAL
Intervention: Pindolol (for patients starting therapy later than 5 days after myocardial infarction)
Number of subjects: 529

Group type: EXPERIMENTAL
Intervention: Pindolol (for patients starting therapy after 12 days)
Number of subjects: 529

Group type: EXPERIMENTAL
Intervention: Pindolol (for patients on digitalis therapy)
Number of subjects: 529
Study: 31377050

Group type: EXPERIMENTAL
Intervention: Negative voices
Number of subjects: 84

Group type: COMPARATOR
Intervention: Neutral voices
Number of subjects: 84

Group type: COMPARATOR
Intervention: Non-voice ambient sounds
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Mindful voice-appraisals
Number of subjects: 84
Study: 30985536

Group type: EXPERIMENTAL
Intervention: Deep neuromuscular block
Number of subjects: 65

Group type: COMPARATOR
Intervention: Moderate neuromuscular block
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Poor surgical conditions
Number of subjects: 65
Study: 30517164

Group type: EXPERIMENTAL
Intervention: Advisory message in the EMR during diabetes consultations
Number of subjects: 2778

Group type: COMPARATOR
Intervention: Standard care without advisory message
Number of subjects: 2778
Study: 26897364

Group type: EXPERIMENTAL
Intervention: Preventive Services Use Self‐Efficacy (PRESS) Scale
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: PRESS Scale
Number of subjects: 242
Study: 24752608

Group type: EXPERIMENTAL
Intervention: In-motion device (Soprano XL 810 nm diode laser in SHR mode)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single pass device (LightSheer Duet 810 nm diode laser)
Number of subjects: 0
Study: 22324753

Group type: EXPERIMENTAL
Intervention: Strength and Balance Group (SBG; n = 63)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Fitness Group (FG; n = 64)
Number of subjects: 280

Group type: COMPARATOR
Intervention: Control Group (CG; n = 80)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Multifaceted Group (MG; n = 73)
Number of subjects: 280
Study: 20307165

Group type: EXPERIMENTAL
Intervention: ADHD group
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 93
Study: 18929280

Group type: EXPERIMENTAL
Intervention: Spinal anesthesia with 7.5 mg of 0.5% hyperbaric bupivacaine
Number of subjects: 50

Group type: COMPARATOR
Intervention: Combined sciatic-femoral nerve blocks using a mixture of 20 mL of lidocaine 2% plus 20 mL of bupivacaine 0.5%
Number of subjects: 50
Study: 15693870

Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin 200 U/kg twice a week, subcutaneously for 6 weeks
Number of subjects: 292

Group type: COMPARATOR
Intervention: Control group (150 premature infants receiving conventional supportive therapy)
Number of subjects: 292
Study: 12390617

Group type: EXPERIMENTAL
Intervention: Buccal prochlorperazine (PCZ) 3 mg
Number of subjects: 114

Group type: COMPARATOR
Intervention: Buccal placebo
Number of subjects: 114

Group type: COMPARATOR
Intervention: Oral ergotamine tartarate (ERG) 1 mg plus caffeine 100 mg
Number of subjects: 114

Group type: COMPARATOR
Intervention: Oral placebo
Number of subjects: 114
Study: 10100056

Group type: EXPERIMENTAL
Intervention: Modified-release nifedipine
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 7598922

Group type: EXPERIMENTAL
Intervention: Sedation with midazolam (Group 2)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Sedation with midazolam and supplemental oxygen (Group 3)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Endoscopy alone (Group 1)
Number of subjects: 58
Study: 2640173

Group type: EXPERIMENTAL
Intervention: Bolus of water
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bolus of barium
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bolus of Coca-Cola
Number of subjects: 0
Study: 30850957

Group type: EXPERIMENTAL
Intervention: CT-P16 5 mg/kg
Number of subjects: 144

Group type: COMPARATOR
Intervention: EU-bevacizumab 5 mg/kg
Number of subjects: 144

Group type: COMPARATOR
Intervention: US-bevacizumab 5 mg/kg
Number of subjects: 144
Study: 25600659

Group type: EXPERIMENTAL
Intervention: 1110 MBq I‐131 (low dose)
Number of subjects: 115

Group type: COMPARATOR
Intervention: 3700 MBq I‐131 (standard dose)
Number of subjects: 115
Study: 25160859

Group type: EXPERIMENTAL
Intervention: Treat & Observe (T&O) regimen
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Wait & Extend (W&E) regimen
Number of subjects: 93
Study: 23457562

Group type: EXPERIMENTAL
Intervention: Intensified counselling on physical activity, diet, and appropriate weight gain
Number of subjects: 399

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 399
Study: 21296315

Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (iNO)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Oxygen
Number of subjects: 29
Study: 18081558

Group type: EXPERIMENTAL
Intervention: Dopaminergic therapy with luteinising hormone‐releasing hormone, thyroid‐releasing hormone, corticotrophin‐releasing hormone and arginine hydrochloride
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Dopaminergic therapy
Number of subjects: 10
Study: 17319338

Group type: EXPERIMENTAL
Intervention: Intraoperative intravenous diclofenac (1 mg/kg i.v. after induction followed by an infusion of 1 mg/kg over 2 hours)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 150
Study: 12728374

Group type: EXPERIMENTAL
Intervention: Laparoscopically assisted resection
Number of subjects: 40

Group type: COMPARATOR
Intervention: Open resection
Number of subjects: 40
Study: 10886272

Group type: EXPERIMENTAL
Intervention: Oral isotretinoin (10‐20 mg three times a week for 2 months)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no oral isotretinoin)
Number of subjects: 60
Study: 8888671

Group type: EXPERIMENTAL
Intervention: Training paradigm for clinical investigators
Number of subjects: 0
Study: 1401445

Group type: EXPERIMENTAL
Intervention: Etched metal RBBs (E-bridges)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Perforated RBBs (P-bridges)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Clearfil F cementation with E-bridges
Number of subjects: 203

Group type: COMPARATOR
Intervention: Maxillary anterior RBBs
Number of subjects: 203

Group type: COMPARATOR
Intervention: Anterior RBBs
Number of subjects: 203

Group type: COMPARATOR
Intervention: Posterior RBBs
Number of subjects: 203
Study: 3926169

Group type: EXPERIMENTAL
Intervention: Cadexomer iodine (Iodosorb)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Standard dressing
Number of subjects: 61
Study: 31375842

Group type: EXPERIMENTAL
Intervention: Younger Appalachians
Number of subjects: 905

Group type: COMPARATOR
Intervention: Older Appalachians
Number of subjects: 905
Study: 29739264

Group type: EXPERIMENTAL
Intervention: Patient-specific positioning guides (PSPGs)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional technique
Number of subjects: 40